Dr Reddy`s posts 10.6% rise in Q3 net profit at Rs 1,379 cr
![](https://portfolio.investmentguruindia.com/uploads/news/dr.reddy.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Pharma major Dr Reddy’s Laboratories on Tuesday reported a net profit of Rs 1,378.9 crore for the October-December quarter of the current financial year, representing a 10.6 per cent increase over the corresponding figures of Rs 1,237.90 crore for the same quarter of the previous fiscal.
The company recorded its highest-ever sales in a quarter during the period, according to the management.
The revenue of the Hyderabad-based company rose 6.6 per cent to Rs 7,237 crore on the back of a strong performance in the US and European markets. The company also recorded 4.7 per cent increase in domestic sales.
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)